+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Intelligence in Drug Discovery Market Research Report by Offering (Services and Software), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995111
  • Report
  • April 2022
  • Region: Global
  • 210 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Aria Pharmaceuticals
  • BenevolentAI Limited
  • Cyclica Inc.
  • Exscientia
  • Microsoft Corporation
  • NVIDIA Corporation
The Global Artificial Intelligence in Drug Discovery Market size was estimated at USD 566.22 million in 2020, USD 701.05 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 25.06% to reach USD 2,166.65 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Artificial Intelligence in Drug Discovery to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Offering, the market was studied across Services and Software.
  • Based on Application, the market was studied across Cardiovascular Disease, Immuno-Oncology, Metabolic Diseases, and Neurodegenerative Diseases.
  • Based on End User, the market was studied across Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Centers and Academic & Government Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Drug Discovery Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Drug Discovery Market, including Aria Pharmaceuticals, Atomwise, Inc., BenevolentAI Limited, BioSymetrics Inc., Cloud Pharmaceuticals, Inc., Cyclica Inc., Deep Genomics Incorporated, Envisagenics, Inc., Exscientia, Insitro, Inc., International Business Machines Corporation, Microsoft Corporation, Novartis AG, NVIDIA Corporation, Owkin, Inc., Verge Genomics Inc., and XtalPi Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Artificial Intelligence in Drug Discovery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Drug Discovery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Drug Discovery Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Drug Discovery Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Drug Discovery Market?
6. What is the market share of the leading vendors in the Global Artificial Intelligence in Drug Discovery Market?
7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence in Drug Discovery Market?
Frequently Asked Questions about the Global Artificial Intelligence in Drug Discovery Market

What is the estimated value of the Global Artificial Intelligence in Drug Discovery Market?

The Global Artificial Intelligence in Drug Discovery Market was estimated to be valued at $566.2 Million in 2020.

What is the growth rate of the Global Artificial Intelligence in Drug Discovery Market?

The growth rate of the Global Artificial Intelligence in Drug Discovery Market is 25.0%, with an estimated value of $2166.7 Million by 2026.

What is the forecasted size of the Global Artificial Intelligence in Drug Discovery Market?

The Global Artificial Intelligence in Drug Discovery Market is estimated to be worth $2166.7 Million by 2026.

Who are the key companies in the Global Artificial Intelligence in Drug Discovery Market?

Key companies in the Global Artificial Intelligence in Drug Discovery Market include Aria Pharmaceuticals, Atomwise, Inc., BenevolentAI Limited, BioSymetrics Inc., Cloud Pharmaceuticals, Inc., Cyclica Inc., Deep Genomics Incorporated, Envisagenics, Inc. and Insitro, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aria Pharmaceuticals
  • BenevolentAI Limited
  • Cyclica Inc.
  • Exscientia
  • Microsoft Corporation
  • NVIDIA Corporation

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Demand to Control Drug Discovery Process and Reduce Cost
5.1.1.2. Increasing Need to Manage the Large Data Generated During Preclinical Studies
5.1.1.3. Increasing Adoption across Biopharmaceutical Companies
5.1.2. Restraints
5.1.2.1. Unavailability of Skilled Professionals
5.1.3. Opportunities
5.1.3.1. AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
5.1.3.2. Increasingly Growing R&D Investments
5.1.4. Challenges
5.1.4.1. Limited Availability of Data Sets
5.2. Cumulative Impact of COVID-19
6. Artificial Intelligence in Drug Discovery Market, by Offering
6.1. Introduction
6.2. Services
6.3. Software
7. Artificial Intelligence in Drug Discovery Market, by Application
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Immuno-Oncology
7.4. Metabolic Diseases
7.5. Neurodegenerative Diseases
8. Artificial Intelligence in Drug Discovery Market, by End User
8.1. Introduction
8.2. Contract Research Organizations
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research Centers and Academic & Government Institutes
9. Americas Artificial Intelligence in Drug Discovery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Artificial Intelligence in Drug Discovery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Artificial Intelligence in Drug Discovery Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aria Pharmaceuticals
13.2. Atomwise, Inc.
13.3. BenevolentAI Limited
13.4. BioSymetrics Inc.
13.5. Cloud Pharmaceuticals, Inc.
13.6. Cyclica Inc.
13.7. Deep Genomics Incorporated
13.8. Envisagenics, Inc.
13.9. Exscientia
13.10. Insitro, Inc.
13.11. International Business Machines Corporation
13.12. Microsoft Corporation
13.13. Novartis AG
13.14. NVIDIA Corporation
13.15. Owkin, Inc.
13.16. Verge Genomics Inc.
13.17. XtalPi Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: DYNAMICS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2026
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2026
FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. SINGAPORE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. TAIWAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. QATAR ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY OFFERING, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IMMUNO-ONCOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 37. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 42. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 47. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. ARGENTINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. BRAZIL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. CANADA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. MEXICO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. INDIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. INDONESIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. JAPAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. SINGAPORE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 67. TAIWAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 68. THAILAND ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 70. FRANCE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 71. GERMANY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 72. ITALY ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 73. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 74. QATAR ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 75. RUSSIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 76. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 77. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 78. SPAIN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 80. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: SCORES
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: BUSINESS STRATEGY
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: PRODUCT SATISFACTION
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: RANKING
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: MERGER & ACQUISITION
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: INVESTMENT & FUNDING
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Aria Pharmaceuticals
  • Atomwise, Inc.
  • BenevolentAI Limited
  • BioSymetrics Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica Inc.
  • Deep Genomics Incorporated
  • Envisagenics, Inc.
  • Exscientia
  • Insitro, Inc.
  • International Business Machines Corporation
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Owkin, Inc.
  • Verge Genomics Inc.
  • XtalPi Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...